It looks like he has his hands full as CEO of Medivation. Just...

It looks like he has his hands full as CEO of Medivation. Just announced recriutment of first patient for his small molecule drug against PC.
"Medivation Announces Treatment of First Patient in Phase 1-2 Clinical Trial of MDV3100 in Hormone-Refractory Prostate Cancer

SAN FRANCISCO, July 25, 2007 /PRNewswire-FirstCall via COMTEX News Network/ --

Medivation, Inc. (Nasdaq: MDVN) today announced treatment of the first patient in a Phase 1-2 clinical trial evaluating MDV3100, the Company's lead development candidate for hormone-refractory prostate cancer.

"Metastatic prostate cancer that continues to progress despite conventional hormone treatments is the second leading cause of cancer death in men and treatment options for this disease are limited," said Howard I. Scher, M.D., lead investigator of the MDV3100 Phase 1-2 trial and chief of the Genitourinary Oncology Service and D. Wayne Calloway Chair in Urologic Oncology at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York. "I consider MDV3100 to be a promising drug in development."

The Phase 1-2 open-label, dose-escalation trial is evaluating the safety and tolerability of MDV3100 when administered orally once daily in patients with hormone-refractory prostate cancer. Up to 62 patients will be included in the trial. Other endpoints include pharmacokinetics, the effect of MDV3100 on serum prostate-specific antigen (PSA) levels (a frequently-used surrogate marker of prostate cancer progression), and disease progression following treatment with MDV3100. The trial is being conducted at several clinical sites in the United States."
Howard Scher is one of the two oncologists in the FDA panel who killed Dendreons Provenge (also going after AIPC) a few months back. He is regarded by the FDA as one of the nations top authorities on PC. I may take a punt on Medivation later, but right now, with SBPs trials finally in sight, I think the better investment is to accumulate a little more SBP first, while it is still at this low price for the move up. Do your own DD. All IMHO
http://investors.medivation.net//ReleaseDetail.cfm?ReleaseID=256299